cysteine has been researched along with prolinedithiocarbamate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frank, N; Osswald, H | 1 |
| Bruccoleri, A; Corsini, E; Galli, CL; Marinovich, M | 1 |
2 other study(ies) available for cysteine and prolinedithiocarbamate
| Article | Year |
|---|---|
Sacrosine- and prolinedithiocarbamate pretreatment increases the therapeutic efficacy of doxorubicin, methotrexate, teniposide, mitoxantrone or cyclohexylchloroethylnitrosourea in leukemia L1210.
Topics: Animals; Antineoplastic Agents; Cysteine; Doxorubicin; Drug Synergism; Female; Leukemia L1210; Lomustine; Methotrexate; Mice; Mice, Inbred DBA; Mitoxantrone; Proline; Sarcosine; Teniposide; Thiocarbamates | 1990 |
In vitro mechanism(s) of ultraviolet-induced tumor necrosis factor-alpha release in a human keratinocyte cell line.
Topics: 4-Aminobenzoic Acid; Antioxidants; Benzophenones; Cell Line; Cysteine; Humans; Interleukin-1; Keratinocytes; L-Lactate Dehydrogenase; Oxidants; Proline; Protein Synthesis Inhibitors; Reactive Oxygen Species; Serine Proteinase Inhibitors; Sulfonic Acids; Sunscreening Agents; Thiocarbamates; Tosylphenylalanyl Chloromethyl Ketone; Transcription Factors; Tumor Necrosis Factor-alpha; Ultraviolet Rays | 1995 |